Loews Corp’s Teva Pharmaceuticals TEVA Stock Holding History

Loews Corp’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-4,530	Closed	-$239K	–	214
2014 Q1	$239K	Buy	+4,530	New	+$209K	﹤0.01%	164
2013 Q3	–	Sell	-5,755	Closed	-$226K	–	201
2013 Q2	$226K	Buy	+5,755	New	+$224K	﹤0.01%	153

Other funds holding TEVA

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Loews Corp's TEVA Position: Q2 2014 in Review

Loews Corp sold out of Teva Pharmaceuticals (TEVA) in Q2 2014, closing a stake of 4,530 shares — an estimated $239K sold.

Loews Corp first reported a position in TEVA in Q2 2013 and held it in 2 quarters. The position peaked at $239K in Q1 2014. 779 funds tracked by Wall St. Rank hold TEVA as of Q2 2014.

Loews Corp reported no remaining Teva Pharmaceuticals position as of Q2 2014 after selling out during the quarter.
Loews Corp sold 4,530 Teva Pharmaceuticals shares in Q2 2014, an estimated $239K.
Loews Corp first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 2 quarters.
Loews Corp's Teva Pharmaceuticals position peaked at $239K in Q1 2014.
779 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2014.

Based on Loews Corp's 13F filing for Q2 2014, filed 13 Aug 2014.